You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Perfluoroperhydrophenanthrene (vitreon) use as a vitreous substitute did not significantly alter intraocular pressure (IOP) or hypotony risk in vitrectomy patients. Vitreon can be safely used for four weeks.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: